262 related articles for article (PubMed ID: 15699396)
1. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
Rosser TL; Vezina G; Packer RJ
Neurology; 2005 Feb; 64(3):553-5. PubMed ID: 15699396
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis type 1 association with moyamoya disease.
Koc F; Yerdelen D; Koc Z
Int J Neurosci; 2008 Aug; 118(8):1157-63. PubMed ID: 18576213
[TBL] [Abstract][Full Text] [Related]
3. Cerebral vasculopathy in children with neurofibromatosis type 1.
Ghosh PS; Rothner AD; Emch TM; Friedman NR; Moodley M
J Child Neurol; 2013 Jan; 28(1):95-101. PubMed ID: 22532547
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of posterior cerebral artery stenosis/occlusion in moyamoya disease].
Kuroda S; Ishikawa T; Houkin K; Iwasaki Y
No Shinkei Geka; 2002 Dec; 30(12):1295-300. PubMed ID: 12491581
[TBL] [Abstract][Full Text] [Related]
5. Neurological complications involving the central nervous system in neurofibromatosis type 1.
Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
[TBL] [Abstract][Full Text] [Related]
6. Intracranial vascular anomalies in patients with morning glory disk anomaly.
Lenhart PD; Lambert SR; Newman NJ; Biousse V; Atkinson DS; Traboulsi EI; Hutchinson AK
Am J Ophthalmol; 2006 Oct; 142(4):644-50. PubMed ID: 17011858
[TBL] [Abstract][Full Text] [Related]
7. Cerebral arteriopathy in children with neurofibromatosis type 1.
Rea D; Brandsema JF; Armstrong D; Parkin PC; deVeber G; MacGregor D; Logan WJ; Askalan R
Pediatrics; 2009 Sep; 124(3):e476-83. PubMed ID: 19706560
[TBL] [Abstract][Full Text] [Related]
8. Cerebral hemodynamics and oxygen metabolism in patients with moyamoya syndrome associated with atherosclerotic steno-occlusive arterial lesions.
Kato H; Shimosegawa E; Oku N; Kimura Y; Kajimoto K; Tanaka M; Hori M; Kitagawa K; Hatazawa J
Cerebrovasc Dis; 2008; 26(1):9-15. PubMed ID: 18511866
[TBL] [Abstract][Full Text] [Related]
9. [Multiple aneurysms of intracranial arteries in neurofibromatosis Recklinghausen type 1].
Becker C; Roth C; Reith W; Fassbender K; Spiegel J
Fortschr Neurol Psychiatr; 2010 May; 78(5):294-5. PubMed ID: 20229451
[TBL] [Abstract][Full Text] [Related]
10. Moyamoya syndrome associated with systemic lupus erythematosus.
Jeong HC; Kim YJ; Yoon W; Joo SP; Lee SS; Park YW
Lupus; 2008 Jul; 17(7):679-82. PubMed ID: 18625642
[TBL] [Abstract][Full Text] [Related]
11. Perfusion MRI abnormalities in the absence of diffusion changes in a case of moyamoya-like syndrome in neurofibromatosis type 1.
El-Koussy M; Lövblad KO; Steinlin M; Kiefer C; Schroth G
Neuroradiology; 2002 Nov; 44(11):938-41. PubMed ID: 12428131
[TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis type 1 associated with moyamoya syndrome in children.
Duat-Rodríguez A; Carceller Lechón F; López Pino MÁ; Rodríguez Fernández C; González-Gutiérrez-Solana L
Pediatr Neurol; 2014 Jan; 50(1):96-8. PubMed ID: 24269170
[TBL] [Abstract][Full Text] [Related]
13. Moyamoya disease in a child with neurofibromatosis type-1.
Kwong KL; Wong YC
J Paediatr Child Health; 1999 Feb; 35(1):108-9. PubMed ID: 10234650
[No Abstract] [Full Text] [Related]
14. The clinical features of adult unilateral moyamoya disease: does it have the same clinical characteristics as typical moyamoya disease?
Ogata T; Yasaka M; Inoue T; Yasumori K; Ibayashi S; Iida M; Okada Y
Cerebrovasc Dis; 2008; 26(3):244-9. PubMed ID: 18648196
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
[TBL] [Abstract][Full Text] [Related]
16. Alagille syndrome associated with angiographic moyamoya.
Connor SE; Hewes D; Ball C; Jarosz JM
Childs Nerv Syst; 2002 Apr; 18(3-4):186-90. PubMed ID: 11981633
[TBL] [Abstract][Full Text] [Related]
17. Cerebrovasculopathy in NF1 associated with ocular and scalp defects.
Smith M; Heran MK; Connolly MB; Heran HK; Friedman JM; Jett K; Lyons CJ; Steinbok P; Armstrong L
Am J Med Genet A; 2011 Feb; 155A(2):380-5. PubMed ID: 21271658
[TBL] [Abstract][Full Text] [Related]
18. 'Moya' than meets the eye: neurofibromatosis type 1 associated with Moyamoya syndrome.
Tan RM; Chng SM; Seow WT; Wong J; Lim CC
Singapore Med J; 2008 Apr; 49(4):e107-9. PubMed ID: 18418511
[TBL] [Abstract][Full Text] [Related]
19. Pediatric moyamoya disease presenting with intracerebral hemorrhage--report of three cases and review of the literature.
Suyama K; Yoshida K; Takahata H; Toda K; Baba H; Ishikawa Y; Hirose M; Nagata I
Clin Neurol Neurosurg; 2008 Mar; 110(3):270-5. PubMed ID: 18035479
[TBL] [Abstract][Full Text] [Related]
20. Progressive unilateral hemispheric atrophy in an infant with neurofibromatosis.
Wintermark P; Meagher-Villemure K; Villemure JG; Maeder-Ingvar M; Maeder P; Ghariani S; Roulet-Perez E
Neuropediatrics; 2007 Apr; 38(2):100-4. PubMed ID: 17712739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
